Magic mushroom compound shows promise for PTSD in early trial
NCT ID NCT06407635
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This early-stage study tests whether psilocybin, the active ingredient in magic mushrooms, can safely help adults with chronic PTSD who are already on antidepressants. Twenty participants will receive psilocybin therapy, with some also getting trauma-focused talk therapy. The goal is to see if psilocybin can reduce PTSD symptoms and improve well-being, while checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Center for Psychedelic and Consciousness Research
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.